144 related articles for article (PubMed ID: 38631695)
1. The early-stage clinical course of anti-pituitary-specific transcription factor-1 hypophysitis diagnosed post-immune checkpoint inhibitor treatment: A case with review of literature.
Urai S; Tomofuji S; Bando H; Kanzawa M; Yamamoto M; Fukuoka H; Tsuda M; Iguchi G; Ogawa W
J Neuroendocrinol; 2024 Apr; ():e13395. PubMed ID: 38631695
[TBL] [Abstract][Full Text] [Related]
2. Clinical features of anti-pituitary-specific transcription factor-1 (PIT-1) hypophysitis: a new aspect of paraneoplastic autoimmune condition.
Urai S; Iguchi G; Kanie K; Bando H; Yamamoto M; Oi Y; Kashitani Y; Iida K; Kanzawa M; Fukuoka H; Takahashi M; Shintani Y; Ogawa W; Takahashi Y
Eur J Endocrinol; 2024 Jan; 190(1):K1-K7. PubMed ID: 38146732
[TBL] [Abstract][Full Text] [Related]
3. Two Cases of anti-PIT-1 Hypophysitis Exhibited as a Form of Paraneoplastic Syndrome not Associated With Thymoma.
Kanie K; Iguchi G; Inuzuka M; Sakaki K; Bando H; Urai S; Shichi H; Fujita Y; Matsumoto R; Suda K; Yamamoto M; Fukuoka H; Taniguchi T; Ogawa W; Takahashi Y
J Endocr Soc; 2021 Mar; 5(3):bvaa194. PubMed ID: 33506159
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune Pituitary Disease: New Concepts With Clinical Implications.
Yamamoto M; Iguchi G; Bando H; Kanie K; Hidaka-Takeno R; Fukuoka H; Takahashi Y
Endocr Rev; 2020 Apr; 41(2):. PubMed ID: 31513261
[TBL] [Abstract][Full Text] [Related]
5. Immune Checkpoint Inhibitor-Induced Hypophysitis and Patterns of Loss of Pituitary Function.
Jessel S; Weiss SA; Austin M; Mahajan A; Etts K; Zhang L; Aizenbud L; Perdigoto AL; Hurwitz M; Sznol M; Herold KC; Kluger HM
Front Oncol; 2022; 12():836859. PubMed ID: 35350573
[TBL] [Abstract][Full Text] [Related]
6. Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitis.
Thapi S; Leiter A; Galsky M; Gallagher EJ
J Immunother Cancer; 2019 Sep; 7(1):248. PubMed ID: 31511065
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic insights into immune checkpoint inhibitor-related hypophysitis: a form of paraneoplastic syndrome.
Kanie K; Iguchi G; Bando H; Urai S; Shichi H; Fujita Y; Matsumoto R; Suda K; Yamamoto M; Fukuoka H; Ogawa W; Takahashi Y
Cancer Immunol Immunother; 2021 Dec; 70(12):3669-3677. PubMed ID: 33977343
[TBL] [Abstract][Full Text] [Related]
8. Early Serum Markers for Immune Checkpoint Inhibitor Induced Hypophysitis in Melanoma Patients.
Mitri F; Machiraju D; Naoum C; Hassel JC
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611018
[TBL] [Abstract][Full Text] [Related]
9. Multiple endocrinopathies, hypercalcaemia and pancreatitis following combined immune checkpoint inhibitor use- case report and review of literature.
Newman C; Kgosidalwa O; Hakami OA; Kennedy C; Grogan L; Agha A
BMC Endocr Disord; 2021 Feb; 21(1):33. PubMed ID: 33639911
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic autoimmune hypophysitis: a novel form of paraneoplastic endocrine syndrome.
Takahashi Y
Endocr J; 2023 Jun; 70(6):559-565. PubMed ID: 37045779
[TBL] [Abstract][Full Text] [Related]
11. Paraneoplastic autoimmune hypophysitis: An emerging concept.
Bando H; Kanie K; Takahashi Y
Best Pract Res Clin Endocrinol Metab; 2022 May; 36(3):101601. PubMed ID: 34876362
[TBL] [Abstract][Full Text] [Related]
12. Clinical heterogeneity of hypophysitis secondary to PD-1/PD-L1 blockade: insights from four cases.
Lupi I; Brancatella A; Cosottini M; Viola N; Lanzolla G; Sgrò D; Dalmazi GD; Latrofa F; Caturegli P; Marcocci C
Endocrinol Diabetes Metab Case Rep; 2019 Oct; 2019():. PubMed ID: 31610523
[TBL] [Abstract][Full Text] [Related]
13. Isolated adrenocorticotropic hormone deficiency and thyroiditis associated with nivolumab therapy in a patient with advanced lung adenocarcinoma: a case report and review of the literature.
Ohara N; Kobayashi M; Ohashi K; Ito R; Ikeda Y; Kawaguchi G; Yoneoka Y; Hasegawa G; Takada T
J Med Case Rep; 2019 Mar; 13(1):88. PubMed ID: 30909965
[TBL] [Abstract][Full Text] [Related]
14. [A Novel Clinical Entity "Anti-PIT-1 Antibody Syndrome"--Autoimmunity against a Transcription Factor].
Takahashi Y; Bando H; Iguchi G
Rinsho Byori; 2015 Apr; 63(4):491-7. PubMed ID: 26536783
[TBL] [Abstract][Full Text] [Related]
15. Adult combined GH, prolactin, and TSH deficiency associated with circulating PIT-1 antibody in humans.
Yamamoto M; Iguchi G; Takeno R; Okimura Y; Sano T; Takahashi M; Nishizawa H; Handayaningshi AE; Fukuoka H; Tobita M; Saitoh T; Tojo K; Mokubo A; Morinobu A; Iida K; Kaji H; Seino S; Chihara K; Takahashi Y
J Clin Invest; 2011 Jan; 121(1):113-9. PubMed ID: 21123951
[TBL] [Abstract][Full Text] [Related]
16. Description of a Brazilian patient bearing the R271W Pit-1 gene mutation.
Rodrigues Martineli AM; Braga M; De Lacerda L; Raskin S; Graf H
Thyroid; 1998 Apr; 8(4):299-304. PubMed ID: 9588494
[TBL] [Abstract][Full Text] [Related]
17. Pleiomorphism plurihormonal Pit-1-positive macroadenoma with central hyperthyroidism: a rare case report and literature review.
Peng G; Guo C; Lv Y; Li D; Zhou L; Shen R; Chen Y; Zheng X; Sun Z; Zheng H; Long M
BMC Endocr Disord; 2022 Dec; 22(1):325. PubMed ID: 36539773
[TBL] [Abstract][Full Text] [Related]
18. Nivolumab-induced hypophysitis causing secondary adrenal insufficiency after transient ACTH elevation.
Sekizaki T; Kameda H; Oba C; Yong Cho K; Nakamura A; Miyoshi H; Osawa T; Shinohara N; Atsumi T
Endocr J; 2019 Oct; 66(10):937-941. PubMed ID: 31217401
[TBL] [Abstract][Full Text] [Related]
19. A novel thymoma-associated autoimmune disease: Anti-PIT-1 antibody syndrome.
Bando H; Iguchi G; Okimura Y; Odake Y; Yoshida K; Matsumoto R; Suda K; Nishizawa H; Fukuoka H; Mokubo A; Tojo K; Maniwa Y; Ogawa W; Takahashi Y
Sci Rep; 2017 Feb; 7():43060. PubMed ID: 28216655
[TBL] [Abstract][Full Text] [Related]
20. Nivolumab-induced hypophysitis in a patient with advanced malignant melanoma.
Okano Y; Satoh T; Horiguchi K; Toyoda M; Osaki A; Matsumoto S; Tomaru T; Nakajima Y; Ishii S; Ozawa A; Shibusawa N; Shimada T; Higuchi T; Chikamatsu K; Yamada M
Endocr J; 2016 Oct; 63(10):905-912. PubMed ID: 27440480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]